Vitreous Substitutes: A Comprehensive Review

Survey of Ophthalmology

Volumn 56, Issue 4, 2011, Pages 300-323

  Kleinberg, Teri T ^a   Tzekov, Radouil T ^a   Stein, Linda ^a   Ravi, Nathan ^b   Kaushal, Shalesh ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Aging; Retinal detachment; Vitreoretinal surgery; Vitreous body; Vitreous detachment; Vitreous substitute

Indexed keywords

ALKANE; AMINO ACID; ASCORBIC ACID; BIOMATERIAL; BIOPOLYMER; CHONDROITIN SULFATE; COLLAGEN; FATTY ACID; FLUORINATED ALKANE; FLUOROCARBON; HEPARAN SULFATE; HYALURONIC ACID; LIPID; PERFLUTREN; PROSTAGLANDIN; SILICONE OIL; SULFUR HEXAFLUORIDE; UNCLASSIFIED DRUG;

ACCOMMODATION; AGING; BIOCHEMICAL COMPOSITION; BIOCOMPATIBILITY; BIODEGRADABILITY; BIOMECHANICS; BLOOD RETINA BARRIER; CATARACT; CELL CULTURE; DIABETIC RETINOPATHY; DRUG DELIVERY SYSTEM; ELASTICITY; ENZYME ACTIVITY; GENE THERAPY; HUMAN; HYDROGEL; IMPLANT; NONHUMAN; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA HOLE; RETINA TEAR; REVIEW; VITREORETINOPATHY; VITREOUS BODY; VITREOUS BODY DETACHMENT;

EYE DISEASES; HUMANS; VISCOELASTIC SUBSTANCES; VITREORETINAL SURGERY; VITREOUS BODY;

EID: 79959255453     PISSN: 00396257     EISSN: 18793304     Source Type: Journal    
DOI: 10.1016/j.survophthal.2010.09.001     Document Type: Review

References (257)

1. Abrams G.W., Azen S.P., Barr C.C., et al. The incidence of corneal abnormalities in the silicone study. Silicone study report 7. Arch Ophthalmol 1995, 113(6):764-769.
2. Abrams G.W., Edelhauser H.F., Aaberg T.M., et al. Dynamics of intravitreal sulfur hexafluoride gas. Invest Ophthalmol 1974, 13(11):863-868.
3. Ai E., Gardner T.W. Current patterns of intraocular gas use in North America. Arch Ophthalmol 1993, 111(3):331-332.
4. Akiba J. Prevalence of posterior vitreous detachment in high myopia. Ophthalmology 1993, 100(9):1384-1388.
5. Ali S., Bettelheim F.A. Distribution of freezable and non-freezable water in bovine vitreous. Curr Eye Res 1984, 3(10):1233-1239.
6. Allen W.S., Otterbein E.C., Wardi A.H. Isolation and characterization of the sulfated glycosaminoglycans of the vitreous body. Biochim Biophys Acta 1977, 498(1):167-175.
7. Altman PL. Blood and Other Body Fluids. Washington, DC, Federation of American Societies for Experimental Biology, 1961.
8. Avitabile T., Marano F., Castiglione F., et al. Biocompatibility and biodegradation of intravitreal hyaluronan implants in rabbits. Biomaterials 2001, 22(3):195-200.
9. Azen S.P., Scott I.U., Flynn H.W., et al. Silicone oil in the repair of complex retinal detachments. A prospective observational multicenter study. Ophthalmology 1998, 105(9):1587-1597.
10. Badrinath S.S., Gopal L., Sharma T., et al. Vitreoschisis in Eales' Disease: pathogenic role and significance in surgery. Retina 1999, 19(1):51-54.
11. Bainbridge J., Herbert E., Gregor Z. Macular holes: vitreoretinal relationships and surgical approaches. Eye 2008, 22(10):1301-1309.
12. Balazs E.A. Fine structure and function of ocular tissues. The vitreous. Int Ophthalmol Clin 1973, 13(3):169-187.
13. Balazs E.A. Functional anatomy of the vitreous. Ocular Anatomy, Embryology and Teratology 1982, 425-440. Harper & Row, Philadelphia, PA. F. Jacobiec (Ed.).
14. Balazs E.A. Physiology of the vitreous body. Vitreous Body in Retina Surgery 1960, 29-48. CV Mosby, St. Louis, MO. C.L. Schepens (Ed.).
15. Balazs E.A., Denlinger J.L. Aging changes in the vitreous. Aging and Human Visual Function 1982, 45-57. Alan Liss Inc, New York. R. Sekuler, D. Kline, K. Dismukes (Eds.).
16. Balazs E.A., Denlinger J.L. The vitreous. The Eye 1984, Vol 1A:535-589. Academic Press, New York. H. Davson (Ed.).
17. Balazs E.A., Denlinger J.L. The vitreous. The Eye 1972, Vol 1A:32-42. Academic Press, New York. H. Davson (Ed.).
18. Balazs E.A., Laurent T.C., Laurent U.B., et al. Studies on the structure of the vitreous body. VIII. Comparative biochemistry. Arch Biochem Biophys 1959, 81(2):464-479.
19. Balazs E.A., Sunblad L. Studies on the structure of the vitreous body. V. Soluble protein content. J Biol Chem 1960, 235:1973-1978.
20. Balazs E.A., Toth L.Z., Ozanics V. Cytological studies on the developing vitreous as related to the hyaloid vessel system. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1980, 213(2):71-85.
21. Barbazetto I.A., Liang J., Chang S., et al. Oxygen tension in the rabbit lens and vitreous before and after vitrectomy. Exp Eye Res 2004, 78(5):917-924.
22. Bartley W., Van Heyningen R., Notton B.M., et al. Fatty acid composition of lipids present in different parts of the ox eye. Biochem J 1962, 85:332-335.
23. Berker N., Batman C., Ozdamar Y., et al. Long-term outcomes of heavy silicone oil tamponade for complicated retinal detachment. Eur J Ophthalmol 2007, 17(5):797-803.
24. Berkowitz B.A., Bansal N., Wilson C.A. Non-invasive measurement of steady-state vitreous lactate concentration. NMR Biomed 1994, 7(6):263-268.
25. Berman E.R., Michaelson I.C. The chemical composition of the human vitreous body as related to age and myopia. Exp Eye Res 1964, 3:9-15.
26. Bettelheim F.A., Mofunanya A. Syneretic response to pressure in bovine and rhesus monkey vitreous. Exp Eye Res 2001, 73(1):133-136.
27. Bishop P.N. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Retin Eye Res 2000, 19(3):323-344.
28. Bishop P.N., Crossman M.V., McLeod D., et al. Extraction and characterization of the tissue forms of collagen types II and IX from bovine vitreous. Biochem J 1994, 299(Pt 2):497-505.
29. Boettner E.A., Wolter J.R. Transmission of the ocular media. Invest Ophthalmol 1962, 1:776-783.
30. Bos K.J., Holmes D.F., Kadler K.E., et al. Axial structure of the heterotypic collagen fibrils of vitreous humour and cartilage. J Mol Biol 2001, 306(5):1011-1022.
31. Bourwieg H., Hoffman K., Riese K. [Content and distribution of low and high molecular substances in the vitreous body. I. Low molecular substances (glucose, lactate, pyruvate) (author's transl)]. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1974, 191(1):53-65.
32. Castoro J.A., Bettelheim F.A. Topographic distribution of water in rhesus monkey vitreus. Ophthalmic Res 1986, 18(2):87-89.
33. Cavalieri F., Miano F., D'Antona P., et al. Study of gelling behavior of poly(vinyl alcohol)-methacrylate for potential utilizations in tissue replacement and drug delivery. Biomacromolecules 2004, 5(6):2439-2446.
34. Chan C.K., Lin S.G., Nuthi A.S., et al. Pneumatic retinopexy for the repair of retinal detachments: a comprehensive review (1986-2007). Surv Ophthalmol 2008, 53(5):443-478.
35. Chang T.S., Pelzek C.D., Nguyen R.L., et al. Inverted pneumatic retinopexy: a method of treating retinal detachments associated with inferior retinal breaks. Ophthalmology 2003, 110(3):589-594.
36. Charteris D.G. Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol 1995, 79(10):953-960.
37. Chaterji S., Kwon I.K., Park K. Smart polymeric gels: redefining the limits of biomedical devices. Prog Polym Sci 2007, 32(8-9):1083-1122.
38. Chaudhuri S.R., Mallam J.N., Chevez-Barrios P., et al. Modulation of adenoviral transduction in vitro and in vivo by hyaluronan and its receptor cd44. Mol Ther 2007, 15(3):566-570.
39. Chen C.H., Chen S.C. Studies on soluble proteins of vitreous in experimental animals. Exp Eye Res 1981, 32(4):381-388.
40. Chen S.C., Wu Y.C., Mi F.L., et al. A novel ph-sensitive hydrogel composed of n, o-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery. J Control Release 2004, 96(2):285-300.
41. Chirila T.V., Tahija S., Hong Y., et al. Synthetic polymers as materials for artificial vitreous body: review and recent advances. J Biomater Appl 1994, 9(2):121-137.
42. Chirila T.V., Hong Y., Dalton P.D., et al. The use of hydrophilic polymers as artificial vitreous. Prog Polym Sci 1998, 23:475-508.
43. Chu T.G., Lopez P.F., Cano M.R., et al. Posterior vitreoschisis. An echographic finding in proliferative diabetic retinopathy. Ophthalmology 1996, 103(2):315-322.
44. Coleman D.J. Unified model for accommodative mechanism. Am J Ophthalmol 1970, 69(6):1063-1079.
45. Colthurst M.J., Williams R.L., Hiscott P.S., et al. Biomaterials used in the posterior segment of the eye. Biomaterials 2000, 21(7):649-665.
46. Cunha-Vaz J.G. The blood-ocular barriers: past, present, and future. Doc Ophthalmol 1997, 93(1-2):149-157.
47. Cunha-Vaz J.G., Maurice D.M. The active transport of fluorescein by the retinal vessels and the retina. J Physiol 1967, 191(3):467-486.
48. Cutler N.L. Transplantation of human vitreous: a preliminary report. Arch Ophthal 1946, 35:615-623.
49. Danser A.H., van den Dorpel M.A., Deinum J., et al. Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J Clin Endocrinol Metab 1989, 68(1):160-167.
50. Denlinger J.L., Eisner G., Balazs E.A. Age-related changes in the vitreus and lens of rhesus monkeys (macaca mulatta). Exp Eye Res 1980, 31(1):67-79.
51. DiMattio J. A comparative study of ascorbic acid entry into aqueous and vitreous humors of the rat and guinea pig. Invest Ophthalmol Vis Sci 1989, 30(11):2320-2331.
52. Doi M., Ning M., Ida H., et al. Histopathologic retinal changes with intravitreous fluorosilicone oil in rabbit eyes. Retina 2000, 20(5):532-536.
53. Douros S., Phillips B.A., Nadel A., et al. Human vitreal prostaglandin levels and proliferative diabetic retinopathy. Doc Ophthalmol 2001, 103(1):27-34.
54. Duvvuri S., Rittenhouse K.D., Mitra A.K. Microdialysis assessment of drug delivery systems for vitreoretinal targets. Adv Drug Deliv Rev 2005, 57(14):2080-2091.
55. Eisner G. Biomicroscopy of the peripheral fundus. Surv Ophthalmol 1972, 17(1):1-28.
56. Federman J.L., Schubert H.D. Complications associated with the use of silicone oil in 150 eyes after retina-vitreous surgery. Ophthalmology 1988, 95(7):870-876.
57. Foos R.Y. Vitreoretinal juncture; topographical variations. Invest Ophthalmol 1972, 11(10):801-808.
58. Foos R.Y., Wheeler N.C. Vitreoretinal juncture. Synchysis senilis and posterior vitreous detachment. Ophthalmology 1982, 89(12):1502-1512.
59. Foster W.J. Vitreous substitutes. Expert Rev Ophthalmol 2008, 3(2):211-218.
60. Friedrich S., Cheng Y.L., Saville B. Finite element modeling of drug distribution in the vitreous humor of the rabbit eye. Ann Biomed Eng 1997, 25(2):303-314.
61. Gabel V.P., Kampik A., Gabel C., et al. Silicone oil with high specific gravity for intraocular use. Br J Ophthalmol 1987, 71(4):262-267.
62. Gao B.B., Chen X., Timothy N., et al. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy. J Proteome Res 2008, 7(6):2516-2525.
63. Gao Q., Mou S., Ge J., et al. A new strategy to replace the natural vitreous by a novel capsular artificial vitreous body with pressure-control valve. Eye 2008, 22(3):461-468.
64. Gartner J. Electron-microscopic study on the fibrillar network and fibrocyte-collagen interactions in the vitreous cortex at the ora serrata of human eyes with special regard to the role of disintegrating cells. Exp Eye Res 1986, 42(1):21-33.
65. Gartner J. The fine structure of the vitreous base of the human eye and pathogenesis of pars planitis. Am J Ophthalmol 1971, 71(6):1317-1327.
66. Gherezghiher T., Koss M.C., Nordquist R.E., et al. Analysis of vitreous and aqueous levels of hyaluronic acid: application of high-performance liquid chromatography. Exp Eye Res 1987, 45(2):347-349.
67. Gloor B.P. The vitreous. Adler's Physiology of the Eye: Clinical Application 1981, 255-276. CV Mosby Co, St Louis, MO. ed 7. R.A. Moses (Ed.).
68. Goes R.M., Nader H.B., Porcionatto M.A., et al. Chondroitin sulfate proteoglycans are structural renewable constituents of the rabbit vitreous body. Curr Eye Res 2005, 30(5):405-413.
69. Gonvers M. Temporary silicone oil tamponade in the management of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 1985, 100(2):239-245.
70. Green W.R. Diagnostic cytopathology of ocular fluid specimens. Ophthalmology 1984, 91(6):726-749.
71. Grimshaw J., Kane A., Trocha-Grimshaw J., et al. Quantitative analysis of hyaluronan in vitreous humor using capillary electrophoresis. Electrophoresis 1994, 15(7):936-940.
72. Hanashima C., Namiki H. Reduced viability of vascular endothelial cells by high concentration of ascorbic acid in vitreous humor. Cell Biol Int 1999, 23(4):287-298.
73. Harocopos G.J., Shui Y.B., McKinnon M., et al. Importance of vitreous liquefaction in age-related cataract. Invest Ophthalmol Vis Sci 2004, 45(1):77-85.
74. Heegaard S., Jensen O.A., Prause J.U. Structure and composition of the inner limiting membrane of the retina. SEM on frozen resin-cracked and enzyme-digested retinas of macaca mulatta. Graefes Arch Clin Exp Ophthalmol 1986, 224(4):355-360.
75. Heimann H., Stappler T., Wong D. Heavy tamponade 1: a review of indications, use, and complications. Eye 2008, 22(10):1342-1359.
76. Henke S.E., Demarais S. Changes in vitreous humor associated with postmortem interval in rabbits. Am J Vet Res 1992, 53(1):73-77.
77. Herbert E., Stappler T., Wetterqvist C., et al. Tamponade properties of double-filling with perfluorohexyloctane and silicone oil in a model eye chamber. Graefes Arch Clin Exp Ophthalmol 2004, 242(3):250-254.
78. Herbrig E., Sandner D., Engelmann K. Anatomical and functional results of endotamponade with heavy silicone oil-densiron 68-in complicated retinal detachment. Ophthalmic Res 2007, 39(4):198-206.
79. Hogan M.J. The vitreous, its structure, and relation to the ciliary body and retina. Proctor award lecture. Invest Ophthalmol 1963, 2:418-445.
80. Hogan M.J., Alvarodo J.A., Weddell J.E. Vitreous body. Histology of the Human Eye 1971, 492-498. WB Saunders, Philadelphia, PA. M.J. Hogan, J.A. Alvarodo, J.E. Weddell (Eds.).
81. Holekamp N.M., Shui Y.B., Beebe D.C. Vitrectomy surgery increases oxygen exposure to the lens: a possible mechanism for nuclear cataract formation. Am J Ophthalmol 2005, 139(2):302-310.
82. Holekamp N.M. The vitreous gel: more than meets the eye. Am J Ophthalmol 2010, 149(1):32-36.
83. Honda Y., Negi A., Kawano S. Ion movement in and out of the vitreous space after vitrectomy. An experimental study on the in vivo eyecup preparation of rabbits. Invest Ophthalmol Vis Sci 1981, 21(Pt 1):126-130.
84. Hong Y., Chirila T.V., Vijayasekaran S., et al. Crosslinked poly(1-vinyl-2-pyrrolidinone) as a vitreous substitute. J Biomed Mater Res 1996, 30(4):441-448.
85. Hong Y., Chirila T.V., Vijayasekaran S., et al. Biodegradation in vitro and retention in the rabbit eye of crosslinked poly(1-vinyl-2-pyrrolidinone) hydrogel as a vitreous substitute. J Biomed Mater Res 1998, 39(4):650-659.
86. Itakura H., Kishi S., Kotajima N., et al. Decreased vitreal hyaluronan levels with aging. Ophthalmologica 2009, 223(1):32-35.
87. Iyer M.N., He F., Wensel T.G., et al. Intravitreal clearance of moxifloxacin. Trans Am Ophthalmol Soc 2005, 103:76-83.
88. Jacobson B. Degradation of glycosaminoglycans by extracts of calf vitreous hyalocytes. Exp Eye Res 1984, 39(3):373-385.
89. Joussen A.M., Kirchhof B., Schrage N., et al. Heavy silicone oil versus standard silicone oil as vitreous tamponade in inferior PVR (HSO study): design issues and implications. Acta Ophthalmol Scand 2007, 85(6):623-630.
90. Jongebloed W.L., Worst J.F. The cisternal anatomy of the vitreous body. Doc Ophthalmol 1987, 67(1-2):183-196.
91. Kakehashi A., Schepens C.L., de Sousa-Neto A., et al. Biomicroscopic findings of posterior vitreoschisis. Ophthalmic Surg 1993, 24(12):846-850.
92. Kamei A., Totani A. Isolation and characterization of minor glycosaminoglycans in the rabbit vitreous body. Biochem Biophys Res Commun 1982, 109(3):881-887.
93. Kang S.I., Bae Y.H. A sulfonamide-based glucose-responsive hydrogel with covalently immobilized glucose oxidase and catalase. J Control Release 2003, 86(1):115-121.
94. Katagiri Y., Iwasaki T., Ishikawa T., et al. Application of thermo-setting gel as artificial vitreous. Jpn J Ophthalmol 2005, 49(6):491-496.
95. Katsumura C., Sugiyama T., Nakamura K., et al. Effects of advanced glycation end products on hyaluronan photolysis: a new mechanism of diabetic vitreopathy. Ophthalmic Res 2004, 36(6):327-331.
96. Katzin H.M., Blum J. Transplantation of vitreous: a preliminary report. Br J Ophthalmol 1947, 31:760-766.
97. Kim H., Robinson M.R., Lizak M.J., et al. Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging. Invest Ophthalmol Vis Sci 2004, 45(8):2722-2731.
98. Kim J.O., Cotlier E. Phospholipid distributions and fatty acid composition of lysophosphatidylcholine and phosphatidylcholine in rabbit aqueous humor, lens and vitreous. Exp Eye Res 1976, 22(6):569-576.
99. Kim R.W., Baumal C. Anterior segment complications related to vitreous substitutes. Ophthalmol Clin North Am 2004, 17(4):569-576. vi.
100. Kincaid M., Green W. Anatomy of the vitreous, retina and choroid. Vitreoretinal Disease: The Essentials 1998, 11-24. Thieme Medical Publishers, New York. ed 1. C.D. Regillo, C. Gary, H.W. Brown, T. Flynn (Eds.).
101. Kirchhof B., Wong D., Van Meurs J., et al. Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery. Am J Ophthalmol 2002, 133(1):95-101.
102. Kishi S., Hagimura N., Shimizu K. The role of the premacular liquefied pocket and premacular vitreous cortex in idiopathic macular hole development. Am J Ophthalmol 1996, 122(5):622-628.
103. Kishi S., Shimizu K. Posterior precortical vitreous pocket. Arch Ophthalmol 1990, 108(7):979-982.
104. Kloeckener-Gruissem B., Bartholdi D., Abdou M.T., et al. Identification of the genetic defect in the original Wagner syndrome family. Mol Vis 2006, 12:350-355.
105. Kociok N., Gavranic C., Kirchhof B., et al. Influence on membrane-mediated cell activation by vesicles of silicone oil or perfluorohexyloctane. Graefes Arch Clin Exp Ophthalmol 2005, 243(4):345-358.
106. Koo H., Jin G.W., Kang H., et al. A new biodegradable crosslinked polyethylene oxide sulfide (PEOS) hydrogel for controlled drug release. Int J Pharm 2009, 374(1-2):58-65.
107. Kopecek J. Hydrogel biomaterials: a smart future?. Biomaterials 2007, 28(34):5185-5192.
108. Kopecek J. Polymer chemistry: swell gels. Nature 2002, 417(6887):388-389. 91.
109. Laicine E.M., Haddad A. Transferrin, one of the major vitreous proteins, is produced within the eye. Exp Eye Res 1994, 59(4):441-445.
110. Laurent U.B., Fraser J.R. Turnover of hyaluronate in the aqueous humour and vitreous body of the rabbit. Exp Eye Res 1983, 36(4):493-503.
111. Lazarus H., Hageman G. In situ characterization of the human hyalocyte. Arch Ophthalmol 1994, 112:1356-1362.
112. Lee D.A., Wilson M.R., Yoshizumi M.O., et al. The ocular effects of gases when injected into the anterior chamber of rabbit eyes. Arch Ophthalmol 1991, 109(4):571-575.
113. Lepori L., Matteoli E., Spanedda A., et al. Combined use of perfluorohexyloctane and silicone oil as intraocular tamponade: an in vitro study. Graefes Arch Clin Exp Ophthalmol 2006, 244(1):79-82.
114. Li W., Zheng J., Zheng Q., et al. Clinical complications of densiron 68 intraocular tamponade for complicated retinal detachment. Eye (Lond) 2010, 24(1):21-28.
115. Liang C., Peyman G.A., Serracarbassa P., et al. An evaluation of methylated collagen as a substitute for vitreous and aqueous humor. Int Ophthalmol 1998, 22(1):13-18.
116. Lim B.L., Vote B. Densiron intraocular tamponade: a case series. Clin Experiment Ophthalmol 2008, 36(3):261-264.
117. Lindner B. Acute posterior vitreous detachment and its retinal complications. Acta Ophthalmologica 1966, 87(Suppl):1-108.
118. Los L.I. The rabbit as an animal model for post-natal vitreous matrix differentiation and degeneration. Eye 2008, 22(10):1223-1232.
119. Los L.I., van der Worp R.J., van Luyn M.J., et al. Age-related liquefaction of the human vitreous body: LM and TEM evaluation of the role of proteoglycans and collagen. Invest Ophthalmol Vis Sci 2003, 44(7):2828-2833.
120. Los L.I., van Luyn M.J., Nieuwenhuis P. Organization of the rabbit vitreous body: lamellae, Cloquet's channel and a novel structure, the 'alae canalis cloqueti'. Exp Eye Res 1999, 69(3):343-350.
121. Lund-Anddersen H., Sander B. The vitreous. Adler's Physiology of the Eye 2007, 293-316. Mosby, St. Louis, MO. ed 10. P. Kaufman, A. Alm (Eds.).
122. Lundquist O., Osterlin S. Glucose concentration in the vitreous of nondiabetic and diabetic human eyes. Graefes Arch Clin Exp Ophthalmol 1994, 232(2):71-74.
123. Mackiewicz J., Maaijwee K., Luke C., et al. Effect of gravity in long-term vitreous tamponade: In vivo investigation using perfluorocarbon liquids and semi-fluorinated alkanes. Graefes Arch Clin Exp Ophthalmol 2007, 245(5):665-675.
124. Malchiodi-Albedi F., Morgillo A., Formisano G., et al. Biocompatibility assessment of silicone oil and perfluorocarbon liquids used in retinal reattachment surgery in rat retinal cultures. J Biomed Mater Res 2002, 60(4):548-555.
125. Mansour A.M. Inverted pneumatic retinopexy. Ophthalmology 2004, 111(7):1435. author reply.
126. Mansour A.M. Pneumatic retinopexy for inferior retinal breaks. Ophthalmology 2005, 112(10):1771-1776.
127. Manzanas L.L., Pastor J.C., Munoz R., et al. Intraocular irrigating solutions and vitrectomy-related changes (in protein, lactic and ascorbic acid) in rabbit vitreous. Ophthalmic Res 1992, 24(2):61-67.
128. Marcus D.M., D'Amico D.J., Mukai S. Pneumatic retinopexy versus scleral buckling for repair of primary rhegmatogenous retinal detachment. Int Ophthalmol Clin 1994, 34(3):97-108.
129. Maruoka S., Matsuura T., Kawasaki K., et al. Biocompatibility of polyvinylalcohol gel as a vitreous substitute. Curr Eye Res 2006, 31(7-8):599-606.
130. Matteucci A., Formisano G., Paradisi S., et al. Biocompatibility assessment of liquid artificial vitreous replacements: relevance of in vitro studies. Surv Ophthalmol 2007, 52(3):289-299.
131. Maurice D. Review: practical issues in intravitreal drug delivery. J Ocul Pharmacol Ther 2001, 17(4):393-401.
132. Mayer H., von der Ohe N. Efficacy of a novel hydrogel formulation in human volunteers. Ophthalmologica 1996, 210(2):101-103.
133. McCuen B.W., de Juan E., Landers M.B., et al. Silicone oil in vitreoretinal surgery. Part 2: results and complications. Retina 1985, 5(4):198-205.
134. Melberg N.S., Thomas M.A. Nuclear sclerotic cataract after vitrectomy in patients younger than 50 years of age. Ophthalmology 1995, 102(10):1466-1471.
135. Meinert H., Roy T. Semifluorinated alkanes-a new class of compounds with outstanding properties for use in ophthalmology. Eur J Ophthalmol 2000, 10(3):189-197.
136. Meredith T. Intravitreal antimicrobials. Intraocular Drug Delivery 2005, 89. Informa Healthcare, New York. G. Jafee, P. Ashton, P.A. Pearson (Eds.).
137. Mertens S., Bednarz J., Engelmann K. Evidence of toxic side effects of perfluorohexyloctane after vitreoretinal surgery as well as in previously established in vitro models with ocular cell types. Graefes Arch Clin Exp Ophthalmol 2002, 240(12):989-995.
138. Meyer K., Palmer J.W. The polysaccharide of vitreous humour. J Biol Chem 1934, 107:629-634.
139. Miyamoto K., Refojo M.F., Tolentino F.I., et al. Fluorinated oils as experimental vitreous substitutes. Arch Ophthalmol 1986, 104(7):1053-1056.
140. Miyamoto T., Inoue H., Sakamoto Y., et al. Identification of a novel splice site mutation of the CSPG2 gene in a Japanese family with Wagner syndrome. Invest Ophthalmol Vis Sci 2005, 46(8):2726-2735.
141. Mojana F., Cheng L., Bartsch D.U., et al. The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results. Am J Ophthalmol 2008, 146(2):218-227.
142. Molnar I., Poitry S., Tsacopoulos M., et al. Effect of laser photocoagulation on oxygenation of the retina in miniature pigs. Invest Ophthalmol Vis Sci 1985, 26(10):1410-1414.
143. Nagarkar R.P., Schneider J.P. Synthesis and primary characterization of self-assembled peptide-based hydrogels. Methods Mol Biol 2008, 474:61-77.
144. Nagasaki H., Shinagawa K., Mochizuki M. Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res 1998, 17(1):77-98.
145. Nakagawa M., Tanaka M., Miyata T. Evaluation of collagen gel and hyaluronic acid as vitreous substitutes. Ophthalmic Res 1997, 29(6):409-420.
146. Naveh N., Belkin M., Ben-Chaim O., et al. Prostanoids in the vitreous of diabetic and nondiabetic human eyes with retinal detachment. Ophthalmic Res 1990, 22(1):3-11.
147. Nickerson C.S., Park J., Kornfield J.A., et al. Rheological properties of the vitreous and the role of hyaluronic acid. J Biomech 2008, 41(9):1840-1846.
148. Nishitsuka K., Kashiwagi Y., Tojo N., et al. Hyaluronan production regulation from porcine hyalocyte cell line by cytokines. Exp Eye Res 2007, 85(4):539-545.
149. Noulas A.V., Theocharis A.D., Feretis E., et al. Pig vitreous gel: macromolecular composition with particular reference to hyaluronan-binding proteoglycans. Biochimie 2002, 84(4):295-302.
150. Noulas A.V., Skandalis S.S., Feretis E., et al. Variations in content and structure of glycosaminoglycans of the vitreous gel from different mammalian species. Biomed Chromatogr 2004, 18:457-461.
151. O'Malley P. The pattern of vitreous syneresis. Advances in Vitreous Surgery 1976, 17-33. Charles C. Thomas, Springfield, IL. H.R. Irvine, P. O'Malley (Eds.).
152. Ogawa K. Scanning electron microscopic study of hyalocytes in the guinea pig eye. Arch Histol Cytol 2002, 65(3):263-268.
153. Oksala A. Ultrasonic findings in the vitreous body at various ages. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1978, 207(4):275-280.
154. Orzalesi N., Migliavacca L., Bottoni F., et al. Experimental short-term tolerance to perfluorodecalin in the rabbit eye: a histopathological study. Curr Eye Res 1998, 17(8):828-835.
155. Osterlin SE. Changes in the macromolecular composition after removal of the lens, in Solanes MP (ed). Proceedings of the XXI International Congress, International Congress Series No. 222. Amsterdam, Excerpta Medica, 1971, pp. 1620-23.
156. Panozzo G., Parolini B. Cataracts associated with posterior segment surgery. Ophthalmol Clin North Am 2004, 17(4):557-568. vi.
157. Pastor J.C. Proliferative vitreoretinopathy: an overview. Surv Ophthalmol 1998, 43(1):3-18.
158. Patrick W.J., Logan R.W. Free amino acid content of the vitreous humour in cot deaths. Arch Dis Child 1988, 63(6):660-662.
159. Peyman G.A., Schulman J.A., Sullivan B. Perfluorocarbon liquids in ophthalmology. Surv Ophthalmol 1995, 39(5):375-395.
160. Ponsioen T.L., van Luyn M.J., van der Worp R.J., et al. Human retinal muller cells synthesize collagens of the vitreous and vitreoretinal interface in vitro. Mol Vis 2008, 14:652-660.
161. Pruett R.C., Calabria G.A., Schepens C.L. Collagen vitreous substitute. I. Experimental study. Arch Ophthalmol 1972, 88(5):540-543.
162. Pruett R.C., Schepens C.L., Freeman H.M. Collagen vitreous substitute. II. Preliminary clinical trials. Arch Ophthalmol 1974, 91(1):29-32.
163. Pruett R.C., Schepens C.L., Swann D.A. Hyaluronic acid vitreous substitute. A six-year clinical evaluation. Arch Ophthalmol 1979, 97(12):2325-2330.
164. Qiao H., Hisatomi T., Sonoda K.H., et al. The characterisation of hyalocytes: the origin, phenotype, and turnover. Br J Ophthalmol 2005, 89(4):513-517.
165. Qiu B., Stefanos S., Ma J., et al. A hydrogel prepared by in situ cross-linking of a thiol-containing poly(ethylene glycol)-based copolymer: a new biomaterial for protein drug delivery. Biomaterials 2003, 24(1):11-18.
166. Reardon A., Heinegard D., McLeod D., et al. The large chondroitin sulphate proteoglycan versican in mammalian vitreous. Matrix Biol 1998, 17(5):325-333.
167. Reddy T.S., Birkle D.L., Packer A.J., et al. Fatty acid composition and arachidonic acid metabolism in vitreous lipids from canine and human eyes. Curr Eye Res 1986, 5(6):441-447.
168. Reddy V.N. Dynamics of transport systems in the eye. Friedenwald lecture. Invest Ophthalmol Vis Sci 1979, 18(10):1000-1018.
169. Regnault F. Vitreous replacement. Trans Ophthalmol Soc UK 1975, 95(3):433-435.
170. Rhodes R.H., Mandelbaum S.H., Minckler D.S., et al. Tritiated fucose incorporation in the vitreous body, lens and zonules of the pigmented rabbit. Exp Eye Res 1982, 34(6):921-931.
171. Rizzo S., Genovesi-Ebert F., Belting C., et al. A pilot study on the use of silicone oil-RMN3 as heavier-than-water endotamponade agent. Graefes Arch Clin Exp Ophthalmol 2005, 243(11):1153-1157.
172. Rizzo S., Genovesi-Ebert F., Vento A., et al. A new heavy silicone oil (HWS 46-3000) used as a prolonged internal tamponade agent in complicated vitreoretinal surgery: a pilot study. Retina 2007, 27(5):613-620.
173. Rizzo S., Genovesi-Ebert F., Vento A., et al. Heavy silicone oil (densiron-68) for the treatment of persistent macular holes: densiron-68 endotamponade for persistent macular holes. Graefes Arch Clin Exp Ophthalmol 2009, 247(11):1471-1476.
174. Roider J., Hoerauf H., Kobuch K., et al. Clinical findings on the use of long-term heavy tamponades (semifluorinated alkanes and their oligomers) in complicated retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol 2002, 240(12):965-971.
175. Rose R.C., Gogia R., Richer S.P. Properties of electrochemically active components in mammalian vitreous humor. Exp Eye Res 1997, 64(5):807-812.
176. Sandner D., Engelmann K. First experiences with high-density silicone oil (densiron) as an intraocular tamponade in complex retinal detachment. Graefes Arch Clin Exp Ophthalmol 2006, 244(5):609-619.
177. Schulze S., Hoerle S., Mennel S., et al. Vitreomacular traction and exudative age-related macular degeneration. Acta Ophthalmol 2008, 86(5):470-481.
178. Schwatz S.D., Alexander R., Hiscott P., et al. Recognition of vitreoschisis in proliferative diabetic retinopathy. A useful landmark in vitrectomy for diabetic traction retinal detachment. Ophthalmology 1996, 103(2):323-328.
179. Scott J.E. The chemical morphology of the vitreous. Eye 1992, 6(Pt 6):553-555.
180. Sebag J. Age-related changes in human vitreous structure. Graefes Arch Clin Exp Ophthalmol 1987, 225(2):89-93.
181. Sebag J. Anatomy and pathology of the vitreo-retinal interface. Eye 1992, 6(Pt 6):541-552.
182. Sebag J. Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease. Graefes Arch Clin Exp Ophthalmol 2004, 242(8):690-698.
183. Sebag J. Diabetic vitreopathy. Ophthalmology 1996, 103(2):205-206.
184. Sebag J. Imaging vitreous. Eye 2002, 16(4):429-439.
185. Sebag J. Structure, function and age-related changes in the humnan vitreous. The vitreous and vitreoretinal interface 1987, 37-57. Springer-Verlag, New York. C.L. Schepens, A. Neetens (Eds.).
186. Sebag J. The Vitreous: Structure, Function, and Pathobiology 1989, Springer-Verlag, New York.
187. Sebag J. The vitreous. Adler's Physiology of the Eye 1992, 268-347. Mosby, New York. ed 9. W. Hart (Ed.).
188. Sebag J. To see the invisible: the quest of imaging vitreous. Dev Ophthalmol 2008, 42:5-28.
189. Sebag J. Vitreoschisis. Graefes Arch Clin Exp Ophthalmol 2008, 246:329-332.
190. Sebag J. Vitreous structure. Principles and Practice of Ophthalmology 2000, 1786-1798. WB Saunders Co, Philadelphia, PA. ed 2. D. Albert, D. Jacobieck, D. Azar (Eds.).
191. Sebag J. Vitreous: the resplendent enigma. Br J Ophthalmol 2009, 93:989-991.
192. Sebag J., Balazs E.A. Human vitreous fibres and vitreoretinal disease. Trans Ophthalmol Soc UK 1985, 104(Pt 2):123-128.
193. Sebag J., Balazs E.A. Morphology and ultrastructure of human vitreous fibers. Invest Ophthalmol Vis Sci 1989, 30(8):1867-1871.
194. Sebag J., Buckingham B., Charles M.A., et al. Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. Arch Ophthalmol 1992, 110(10):1472-1476.
195. Sebag J., Tang M. Pneumatic retinopexy using only air. Retina 1993, 13:8-12.
196. Shafer D.M. Human vitreous transplantation. Ann R Coll Surg Engl 1976, 58(1):25-33.
197. Shui Y.B., Fu J.J., Garcia C., et al. Oxygen distribution in the rabbit eye and oxygen consumption by the lens. Invest Ophthalmol Vis Sci 2006, 47(4):1571-1580.
198. Shui Y.B., Holekamp N.M., Kramer B.C., et al. The gel state of the vitreous and ascorbate-dependent oxygen consumption: relationship to the etiology of nuclear cataracts. Arch Ophthalmol 2009, 127(4):475-482.
199. Slevin M., Krupinski J., Gaffney J., et al. Hyaluronan-mediated angiogenesis in vascular disease: uncovering RHAMM and CD44 receptor signaling pathways. Matrix Biol 2007, 26(1):58-68.
200. Smets R.M., Neetens A. Historical introduction. The Vitreous and Vitreoretinal Interface 1987, 5-10. Springer-Verlag, New York. C.L. Schepens, A. Neetens (Eds.).
201. Snowden J.M., Swann D.A. Vitreous structure. V. The morphology and thermal stability of vitreous collagen fibers and comparison to articular cartilage (type II) collagen. Invest Ophthalmol Vis Sci 1980, 19(6):610-618.
202. Sommer F., Brandl F., Weiser B., et al. FACS as useful tool to study distinct hyalocyte populations. Exp Eye Res 2009, 88(5):995-999.
203. Sommer F., Kobuch K., Brandl F., et al. Ascorbic acid modulates proliferation and extracellular matrix accumulation of hyalocytes. Tissue Eng 2007, 13(6):1281-1289.
204. Sommer F., Pollinger K., Brandl F., et al. Hyalocyte proliferation and ecm accumulation modulated by BFGF and TGF-beta1. Graefes Arch Clin Exp Ophthalmol 2008, 246(9):1275-1284.
205. Soppimath K.S., Aminabhavi T.M., Dave A.M., et al. Stimulus-responsive " smart" hydrogels as novel drug delivery systems. Drug Dev Ind Pharm 2002, 28(8):957-974.
206. Sparrow J.R., Ortiz R., MacLeish P.R., et al. Fibroblast behavior at aqueous interfaces with perfluorocarbon, silicone, and fluorosilicone liquids. Invest Ophthalmol Vis Sci 1990, 31(4):638-646.
207. Spraul C.W., Grossniklaus H.E. Vitreous hemorrhage. Surv Ophthalmol 1997, 42(1):3-39.
208. Sramek S.J., Wallow I.H., Tewksbury D.A., et al. An ocular renin-angiotensin system. Immunohistochemistry of angiotensinogen. Invest Ophthalmol Vis Sci 1992, 33(5):1627-1632.
209. Stappler T., Williams R., Gibran S.K., et al. A guide to the removal of heavy silicone oil. Br J Ophthalmol 2008, 92(6):844-847.
210. Stay M.S., Xu J., Randolph T.W., et al. Computer simulation of convective and diffusive transport of controlled-release drugs in the vitreous humor. Pharm Res 2003, 20(1):96-102.
211. Stefaniotou M.I., Aspiotis M.V., Kitsos G.D., et al. Our experience with perfluorohexyloctane (F6H8) as a temporary endotamponade in vitreoretinal surgery. Eur J Ophthalmol 2002, 12(6):518-522.
212. Streeten B.W. Vitreous asteroid bodies. Ultrastructural characteristics and composition. Arch Ophthalmol 1982, 100(6):969-975.
213. Suri S., Banerjee R. In vitro evaluation of in situ gels as short term vitreous substitutes. J Biomed Mater Res A 2006, 79(3):650-664.
214. Swann D.A. Chemistry and biology of the vitreous body. Int Rev Exp Pathol 1980, 22:1-64.
215. Swann D.A., Constable I.J. Vitreous structure. I. Distribution of hyaluronate and protein. Invest Ophthalmol 1972, 11(3):159-163.
216. Swindle K.E., Hamilton P.D., Ravi N. In situ formation of hydrogels as vitreous substitutes: viscoelastic comparison to porcine vitreous. J Biomed Mater Res A 2008, 87(3):656-665.
217. Swindle-Reilly K.E., Shah M., Hamilton P.D., et al. Rabbit study of an in situ forming hydrogel vitreous substitute. Invest Ophthalmol Vis Sci 2009, 50(10):4840-4846.
218. Szirmai J.A., Balazs E.A. Studies on the structure of the vitreous body. III. Cells in the cortical layer. AMA Arch Ophthalmol 1958, 59(1):34-48.
219. Takano S., Ishiwata S., Nakazawa M., et al. Determination of ascorbic acid in human vitreous humor by high-performance liquid chromatography with UV detection. Curr Eye Res 1997, 16(6):589-594.
220. Teng C.C., Chi H.H. Vitreous changes and the mechanism of retinal detachment. Am J Ophthalmol 1957, 44(3):335-356.
221. Theelen T., Tilanus M.A., Klevering B.J. Intraocular inflammation following endotamponade with high-density silicone oil. Graefes Arch Clin Exp Ophthalmol 2004, 242(7):617-620.
222. Theocharis D.A., Skandalis S.S., Noulas A.V., et al. Hyaluronan and chondroitin sulfate proteoglycans in the supramolecular organization of the mammalian vitreous body. Connect Tissue Res 2008, 49(3):124-128.
223. Theodossiadis G. Vitreous inflammatory reaction. Vitreous inflammation in rabbits, induced by saline, air, or sodium salt of hyaluronic acid. Mod Probl Ophthalmol 1977, 18:265-270.
224. Thomas M.A., O'Grady G.E., Swartz S.L. Prostaglandin levels in human vitreous. Br J Ophthalmol 1985, 69(4):275-279.
225. Thompson J.T. The absorption of mixtures of air and perfluoropropane after pars plana vitrectomy. Arch Ophthalmol 1992, 110(11):1594-1597.
226. Tillis T.N., Murray D.L., Schmidt G.J., et al. Preretinal oxygen changes in the rabbit under conditions of light and dark. Invest Ophthalmol Vis Sci 1988, 29(6):988-991.
227. Tognetto D., Lepori L., Lapasin R., et al. A new heavy internal tamponade in vitreoretinal surgery: an in vitro study. Eye 2008, 22(8):1082-1088.
228. Truscott R.J. Age-related nuclear cataract-oxidation is the key. Exp Eye Res 2005, 80(5):709-725.
229. Tsen G., Halfter W., Kroger S., et al. Agrin is a heparan sulfate proteoglycan. J Biol Chem 1995, 270(7):3392-3399.
230. Tseng W., Cortez R.T., Ramirez G., et al. Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery. Am J Ophthalmol 2004, 137(6):1105-1115.
231. Van Bockxmeer F.M., Martin C.E., Constable I.J. Iron-binding proteins in vitreous humour. Biochim Biophys Acta 1983, 758(1):17-23.
232. Vaughan-Thomas A., Gilbert S.J., Duance V.C. Elevated levels of proteolytic enzymes in the aging human vitreous. Invest Ophthalmol Vis Sci 2000, 41(11):3299-3304.
233. Veckeneer M.A., de Voogd S., Lindstedt E.W., et al. An epidemic of sticky silicone oil at the rotterdam eye hospital. Patient review and chemical analyses. Graefes Arch Clin Exp Ophthalmol 2008, 246(6):917-922.
234. Versura P., Cellini M., Torreggiani A., et al. The biocompatibility of silicone, fluorosilicone and perfluorocarbon liquids as vitreous tamponades. An ultrastructural and immunohistochemical study. Ophthalmologica 2001, 215(4):276-283.
235. Vijayasekaran S., Chirila T.V., Hong Y., et al. Poly(1-vinyl-2-pyrrolidinone) hydrogels as vitreous substitutes: histopathological evaluation in the animal eye. J Biomater Sci Polym Ed 1996, 7(8):685-696.
236. Walker F., Patrick R.S. Constituent monosaccharides and hexosamine concentration of normal human vitreous humour. Exp Eye Res 1967, 6(3):227-232.
237. Weber H., Landwehr G., Kilp H., et al. The mechanical properties of the vitreous of pig and human donor eyes. Ophthalmic Res 1982, 14(5):335-343.
238. Wetterqvist C., Wong D., Williams R., et al. Tamponade efficiency of perfluorohexyloctane and silicone oil solutions in a model eye chamber. Br J Ophthalmol 2004, 88(5):692-696.
239. Wheeldon I.R., Barton S.C., Banta S. Bioactive proteinaceous hydrogels from designed bifunctional building blocks. Biomacromolecules 2007, 8(10):2990-2994.
240. Wilkinson C., Rice T. Instrumentation, materials, and treatment alternatives. Michels Retinal Detachment 1996, 391-461. Mosby, St. Louis, MO. ed 2. L. Craven (Ed.).
241. Wilson C.A., Berkowitz B.A., Srebro R. Perfluorinated organic liquid as an intraocular oxygen reservoir for the ischemic retina. Invest Ophthalmol Vis Sci 1995, 36(1):131-141.
242. Wise G.N. Relationship of idiopathic preretinal macular fibrosis to posterior vitreous detachment. Am J Ophthalmol 1975, 79(3):358-362.
243. Wolf S., Schon V., Meier P., et al. Silicone oil-RMN3 mixture (" Heavy silicone oil" ) as internal tamponade for complicated retinal detachment. Retina 2003, 23(3):335-342.
244. Wong D., Kumar I., Quah S.A., et al. Comparison of postoperative intraocular pressure in patients with densiron-68 vs conventional silicone oil: a case-control study. Eye 2009, 23(1):190-194.
245. Wong D., Van Meurs J.C., Stappler T., et al. A pilot study on the use of a perfluorohexyloctane/silicone oil solution as a heavier than water internal tamponade agent. Br J Ophthalmol 2005, 89(6):662-665.
246. Wong R.W., Richa D.C., Hahn P., et al. Iron toxicity as a potential factor in AMD. Retina 2007, 27(8):997-1003.
247. Worst J.G. Cisternal systems of the fully developed vitreous body in the young adult. Trans Ophthalmol Soc UK 1977, 97(4):550-554.
248. Worst J.G.F., Los L. Functional anatomy of the vitreous. Cisternal Anatomy of the Vitreous 1995, 33-50. Kugler Publications, Amsterdam. J.G.F. Worst, L. Los (Eds.).
249. Wu C.W., Sauter J.L., Johnson P.K., et al. Identification and localization of major soluble vitreous proteins in human ocular tissue. Am J Ophthalmol 2004, 137(4):655-661.
250. Yang H., Wang R., Gu Q., et al. Feasibility study of chitosan as intravitreous tamponade material. Graefes Arch Clin Exp Ophthalmol 2008, 246(8):1097-1105.
251. Yaws CL, Braker W. Matheson Gas Data Book. Appendix 18, Refractive index, dipole moment and radius of gyration. New York, McGraw-Hill Professional, 2001, ed 7, p 919.
252. Yonemoto J., Noda Y., Masuhara N., et al. Age of onset of posterior vitreous detachment. Curr Opin Ophthalmol 1996, 7(3):73-76.
253. Yu L., Ding J. Injectable hydrogels as unique biomedical materials. Chem Soc Rev 2008, 37(8):1473-1481.
254. Yurchenko P. Assmbly of laminin and type IV collagen into basement membrane networks. Extracellular Matrix Assembly and Structure 1994, 351-388. Academic Press, San Diego. P. Yurchenko, D. Birk, R. Mecham (Eds.).
255. Zeana D., Becker J., Kuckelkorn R., et al. Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal. Experimental perfluorohexyloctane substitution. Int Ophthalmol 1999, 23(1):17-24.
256. Zhang X.M., Ohishi K., Hiramitsu T. Microdialysis measurement of ascorbic acid in rabbit vitreous after photodynamic reaction. Exp Eye Res 2001, 73(3):303-309.
257. Zilis J.D., McCuen B.W., de Juan E., et al. Results of silicone oil removal in advanced proliferative vitreoretinopathy. Am J Ophthalmol 1989, 108(1):15-21.